AMPH icon

Amphastar Pharmaceuticals
AMPH

Overview Fund Activity

95 hedge funds and large institutions have $168M invested in Amphastar Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 42 increasing their positions, 22 reducing their positions, and 10 closing their positions.

Holders
95
Holders Change
–
Holders Change %
0%
% of All Funds
2.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
42
Reduced
22
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$29.9M
2
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$3.09M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$17.2M
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$5.43M
5
SGAM
5
Smith Group Asset Management
Texas
$1.37M

Top Sellers

1
BC
1
Broadfin Capital
New York
$0
2
Arrowstreet Capital
2
Arrowstreet Capital
Massachusetts
$579K
3
TC
3
TFS Capital
Pennsylvania
$928K
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$4.78M
5
JG
5
Jefferies Group
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
ACI
101
AMP Capital Investors
Australia
– – -21,814 Closed
Capital Fund Management (CFM)
102
Capital Fund Management (CFM)
France
– – -18,974 Closed
GCP
103
GSA Capital Partners
United Kingdom
– – -11,500 Closed
Walleye Trading
104
Walleye Trading
New York
– – -7,500 Closed
BNP Paribas Financial Markets
105
BNP Paribas Financial Markets
France
– – -6,098 Closed
Simplex Trading
106
Simplex Trading
Illinois
– – – –
1 2 3 4
5